Strumph Peter M 4
4 · Nile Therapeutics, Inc. · Filed Jan 20, 2009
Insider Transaction Report
Form 4
Strumph Peter M
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2009-01-16+149,148→ 149,148 totalExercise: $0.88Exp: 2019-01-15→ Common Stock (149,148 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option are fully vested and immediately exercisable.